Back to Journals » International Journal of Nanomedicine » Call For Papers

International Journal of Nanomedicine

ISSN: 1178-2013


The following Article Collections/ Thematic Series are currently open for submissions:

Surfactants in Nanomedicine: Enhancing Efficacy and Potential Applications

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Surfactants in Nanomedicine: Enhancing Efficacy and Potential Applications", organized by Guest Advisors Dr. Taiki Miyazawa (Tohoku university, Japan), Dr. Maharshi Bhaswant (Tohoku university, Japan) and Dr. Hiroaki Komuro (Cedars-Sinai Medical Center, United States).

Surfactants, classified as amphiphilic compounds, have evolved significantly in response to recent technological advancements. These innovations enable precise tuning of their charge, chain length, and physicochemical properties to meet specific needs. These versatile compounds play a pivotal role in a wide array of applications, spanning from adhesives, paints, cosmetics, household and industrial cleaners, oilfield chemicals, pesticides, plastics, textiles, food, and pharmaceuticals. They are indispensable for promoting a healthy and comfortable human lifestyle.

Notably, there is a growing utilization of surfactants in the burgeoning field of nanomedicine, driven by strides in nanotechnology. Prominent examples include their role as templates for crafting nanoparticles, as key components in niosomes, and as solubilizers for proteins and antibodies. Furthermore, surfactants hold the potential to impart advanced functionalities in nanomedicine, including the ability to regulate capture by the mononuclear phagocyte system (MPS) within the body, mitigate hemolysis, target specific organs, and mitigate adverse drug effects.

The potential of surfactants in nanomedicine is expansive, and research results have demonstrated significant promise in various medical domains. These include oncology, cardiovascular diseases, neurodegenerative diseases, gastroenterological diseases, dermatological conditions, ocular disorders, and immunotherapy. Particularly noteworthy are the achievements observed when utilizing surfactants series of poloxamer and polysorbate. In essence, surfactants, with their enduring historical legacy spanning ancient civilizations to the modern era, remain indispensable to human existence. They continue to adapt and find relevance in emerging fields of application.

The primary objective of this collection of articles is to spotlight the forefront of nanomedicine research harnessing the potential of surfactants. This endeavor takes place against the backdrop of an escalating demand for these compounds. Given the wide-reaching versatility of surfactants across a spectrum of research domains, this collection aspires to function as a conduit. It aims to attract not only specialists in nanomedicine but also thought leaders from related disciplines. Through this interdisciplinary exchange, we anticipate the initiation of innovative avenues of scientific exploration.

This Article Collection comprehensively explores various facets of nanomedicine research leveraging surfactants.

The potential applications encompass a wide spectrum and include, but are not restricted to, the following areas:

• Impact of Surfactants on the Biocompatibility of Nanomedicine

• Enhancing Nanomedicine's Ability to Evade the Mononuclear Phagocyte System (MPS)

• Augmenting Nanomedicine's Targeting Precision

• Preserving the Physical and Chemical Stability of Nanomedicine

• Functional Evaluation of Niosomes Utilizing Surfactants as Building Blocks

• Influence of Surfactants on the Antimicrobial Activity of Nanomedicine

• Modulation of Drug Release Rate by Surfactants in Nanomedicine

• Enhancing Nanomedicine's Dispersibility

• Surfactant-Mediated Enhancement of Therapeutic Efficacy

• Future Directions and Challenges in the field of nanomedicine utilizing surfactants

This comprehensive coverage underscores the pivotal role surfactants play in advancing nanomedicine research across a multitude of dimensions, offering a promising avenue for innovations in healthcare and therapeutic interventions.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code JWYJL to indicate that your article should be considered for this Collection.

The manuscript submission deadline is 31 May 2024

Please contact Haoyang Yi at [email protected] with any queries regarding this Article Collection. 

Guest advisors

Dr. Taiki Miyazawa, Tohoku university

[email protected]

Taiki Miyazawa has been an associate professor at the Tohoku university, New industry creation hatchery center (Niche). He received Ph.D. from Tohoku university in April 2014. His research focuses on carotenoids, polyphenols, and vitamins with the aim of elucidating the biological activities of these components. He is also working on the application of nanoparticle-based nanomedicine to efficiently utilize these food components and other pharmaceuticals in the body. He also been developing an AI system for explain the physiological functions exhibited by thousands of molecular species in foods. 

Dr. Maharshi Bhaswant, Tohoku university

[email protected]

Maharshi Bhaswant is currently a JSPS research fellow at Tohoku University, based at the New Industry Creation Hatchery Center (Niche). He completed his Ph.D. degree at Victoria University in Melbourne, Australia, in the year 2016. His primary research focus revolves around natural molecules, with the overarching goal of gaining a comprehensive understanding of their cardiometabolic properties and functions. Furthermore, his research extends to the practical application of micronutrients, with the aim of effectively fortifying these vital components within various food constituents, thereby contributing to improved health and overall well-being. Maharshi's research interests also encompass the identification and assessment of novel therapeutic molecules for the treatment of chronic diseases. 

Dr. Hiroaki Komuro, Cedars-Sinai Medical Center

[email protected]

Hiroaki Komuro has been a postdoctoral fellow at the Smidt Heart Institute, Cedars-Sinai Medical Center, US. In march 2021, he received a Ph.D under the guidance of professor Tetsuo Sasano at Department of Cardiovascular Medicine, Tokyo Medical and Dental University in Japan. His research interests include development of therapeutic and diagnostic using biomaterials, especially extracellular vesicles.

View all papers in this article collection

Unveiling the Potential of Nanobiomaterials: Pioneering Insights into Biomedical Engineering

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Unveiling the Potential of Nanobiomaterials: Pioneering Insights into Biomedical Engineering", organized by Guest Advisor Dr. Narsimha Mamidi, University of Wisconsin-Madison, United States and Editor-in-Chief Dr. R.D.K. Misra, University of Texas at El Paso, United States.

Nanobiomaterials (NBMs) are a class of materials that combine the principles of nanotechnology and biomaterials to create innovative solutions for various biomedical applications. They are designed and engineered at the nanoscale level, which typically involves working with materials and structures that range from 1 to 100 nanometers in size. The field of NBMs has gained significant attention in recent years due to its potential to revolutionize medicine and healthcare. NBMs have unique properties and interactions at the nanoscale that make them suitable for a wide range of applications in biology, medicine, and medical devices. Some of the key characteristics and applications of NBMs include:

High surface area: Due to their nanoscale size, NBMs have a large surface area relative to their volume. This property is advantageous for applications such as drug delivery, where increased surface area allows for better drug loading and release kinetics.

Enhanced bioactivity: NBMs can be functionalized with specific molecules to improve their interactions with biological systems, such as cells and tissues. This enables better biocompatibility and targeted delivery of therapeutic agents.

Drug delivery: NBMs can be engineered to encapsulate and deliver drugs, proteins, or genetic material to specific sites in the body. This targeted drug delivery can improve the efficacy of treatments while reducing side effects.

Tissue engineering: NBMs play a vital role in tissue engineering and regenerative medicine. They can serve as scaffolds to support cell growth and tissue formation, facilitating the repair and regeneration of damaged tissues and organs.

Diagnostics: NBMs are utilized in diagnostic applications, such as nanosensors for detecting biomarkers, nanoprobes for imaging, and nanoparticle-based assays for disease detection.

Therapeutics: Some NBMs have inherent therapeutic properties, such as antibacterial nanoparticles that can combat infections or nanoscale materials with photothermal or photodynamic properties for cancer therapy.

Implants and medical devices: NBMs are used in the development of advanced implants and medical devices with improved mechanical properties, biocompatibility, and reduced risk of adverse reactions.

Despite their promising potential, the development and application of NBMs also raise concerns about their long-term safety, toxicity, and environmental impact. As research in this field continues to progress, it is essential to balance innovation with a thorough understanding of the potential risks and benefits associated with these novel materials.

In this Article Collection, we collect research devoted to the interaction between NBMs and tissue/cell, the effect of size, morphology, shape, and surface of NBMs on their toxicity, biocompatibility, immunogenicity, design of novel biodegradable and biocompatible NBMs, instrumentation, and technologies to analyze biocompatibility of NBMs and challenges to overcome the toxicity of NBMs. This exposure could potentially pave the way for exciting and innovative concepts of NBMs and provide game-changing solutions for several research areas, including tissue engineering, drug delivery, medical devices, biosensors, and other biomedical applications.

This topic covers several successful models of NBMs, including polymer-based NBMs, magnetic and gold nanoparticles, quantum dots, and inorganic-organic-based and carbon nanomaterials (CNMs)-based NBMs, used in biomedical engineering and biosensing applications. We are specifically emphasizing articles narrating the cell and NBMs interaction, toxicity and biocompatibility advancing protocol, structural-property relationship, degradation of NBMs, etc. Topics include but are not limited to: 

  • Biocompatibility Assessment of NBMs:
  • Designing NBMs with multiple functions for medical purposes.
  • Developing drug delivery strategies using NBMs as carriers.
  • Using in vitro/in vivo approaches to understand the biological effects of NBMs.

Overall, it is hoped that this Article Collection will facilitate the assembling of new collaborations and motivate new generations to engage in the engineering of NBMs for a wide range of applications. 

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code EJJKG to indicate that your article should be considered for this Collection.

The manuscript submission deadline is 30 September 2024.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection. 

Guest advisors

Dr. Narsimha Mamidi, University of Wisconsin-Madison

[email protected]

Dr. Narsimha Mamidi is now serving as Scientist-I at WiscNano, University of Wisconsin-Madison, Wisconsin, USA. His primary research focus revolves around pioneering the development of Nanoformulations for the co-delivery of drugs and genes, with a particular emphasis on cancer immunotherapy. His overarching objective is to advance the application of Nanoformulations for clinical use, revolutionizing the landscape of immunotherapy. This endeavor entails the creation of user-friendly drug delivery platforms tailored for a spectrum of cancer types, including but not limited to triple-negative breast cancer, lung cancer, liver cancer, brain cancer, and pancreatic cancer.

Dr. R.D.K. Misra, University of Texas at El Paso

[email protected]

Dr. Misra is a Professor in the Department of Metallurgical, Materials, and Biomedical Engineering at the University of Texas at El Paso, USA. He is also the Editor-in-Chief of the International Journal of Nanomedicine. His inter-/multidisciplinary research interests include advanced manufacturing of biomedical devices, nanoparticle-systems for drug delivery, antimicrobial systems, super-hydrophobic nanocomposites for wound dressing, nanostructured implants, impact of nanostructured surfaces on protein adsorption, quantum dots for bio-imaging, and bio-nano interactions. His research programs involve the use of a broad spectrum of biomaterials characterization techniques such as electron microscopy, confocal microscopy, X-ray diffraction, EBSD, atomic force microscopy, and mechanical testing, to list a few.

View all papers in this article collection


Call For Papers

Editor-in-Chief: Professor R.D.K. Misra


To see where the International Journal of Nanomedicine is indexed online view the Journal Metrics.

What is the advantage to you of publishing in the International Journal of Nanomedicine?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although the International Journal of Nanomedicine receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. The International Journal of Nanomedicine has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed Central
The International Journal of Nanomedicine is indexed on PubMed Central and MedLine (title abbreviation: Int J Nanomedicine). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely

Professor R.D.K. Misra

Editor-in-Chief

International Journal of Nanomedicine

Email: Editor-in-Chief